127 related articles for article (PubMed ID: 38142494)
21. Near-infrared ratiometric fluorescent strategy for butyrylcholinesterase activity and its application in the detection of pesticide residue in food samples and biological imaging.
Yuan W; Wan C; Zhang J; Li Q; Zhang P; Zheng K; Zhang Q; Ding C
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Sep; 297():122719. PubMed ID: 37043836
[TBL] [Abstract][Full Text] [Related]
22. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Duysen EG; Li B; Lockridge O
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):523-8. PubMed ID: 19416087
[TBL] [Abstract][Full Text] [Related]
23. Fluorescent Determination of Butyrylcholinesterase Activity and Its Application in Biological Imaging and Pesticide Residue Detection.
Zhang Q; Fu C; Guo X; Gao J; Zhang P; Ding C
ACS Sens; 2021 Mar; 6(3):1138-1146. PubMed ID: 33503372
[TBL] [Abstract][Full Text] [Related]
24. An ultrasensitive and selective near-infrared fluorescent probe for tracking carboxylesterases with large Stokes shift in living cells and mice.
Zhang W; Qi C; Wang X; Fu Z; Zhang J; Zhou Y; Wang Y
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Mar; 308():123708. PubMed ID: 38042124
[TBL] [Abstract][Full Text] [Related]
25. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Darreh-Shori T; Vijayaraghavan S; Aeinehband S; Piehl F; Lindblom RP; Nilsson B; Ekdahl KN; Långström B; Almkvist O; Nordberg A
Neurobiol Aging; 2013 Nov; 34(11):2465-81. PubMed ID: 23759148
[TBL] [Abstract][Full Text] [Related]
26. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.
Mesulam M; Guillozet A; Shaw P; Quinn B
Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688
[TBL] [Abstract][Full Text] [Related]
27. A direct assay of butyrylcholinesterase activity using a fluorescent substrate.
Kang S; Lee S; Yang W; Seo J; Han MS
Org Biomol Chem; 2016 Sep; 14(37):8815-8820. PubMed ID: 27714157
[TBL] [Abstract][Full Text] [Related]
28. Developing a Two-Photon "AND" Logic Probe and Its Application in Alzheimer's Disease Differentiation.
Guo J; Sun J; Liu D; Liu J; Gui L; Luo M; Kong D; Wusiman S; Yang C; Liu T; Yuan Z; Li R
Anal Chem; 2023 Nov; 95(46):16868-16876. PubMed ID: 37947381
[TBL] [Abstract][Full Text] [Related]
29. Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Jasiecki J; Limon-Sztencel A; Żuk M; Chmara M; Cysewski D; Limon J; Wasąg B
Sci Rep; 2019 Mar; 9(1):5223. PubMed ID: 30914707
[TBL] [Abstract][Full Text] [Related]
30. Construction of a copper nanocluster/MnO
Chen S; Li Z; Huang Z; Jia Q
J Mater Chem B; 2022 Jun; 10(25):4783-4788. PubMed ID: 35343562
[TBL] [Abstract][Full Text] [Related]
31. Quantum dots-based fluorescent probes for turn-on and turn-off sensing of butyrylcholinesterase.
Chen Z; Ren X; Meng X; Tan L; Chen D; Tang F
Biosens Bioelectron; 2013 Jun; 44():204-9. PubMed ID: 23428734
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of novel carboxamide- and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors.
Ozturk O; Farouk FM; Ooi L; Law CSW; Muhammed MT; Aki-Yalcin E; Yeong KY
Mol Divers; 2022 Oct; 26(5):2863-2876. PubMed ID: 35780204
[TBL] [Abstract][Full Text] [Related]
33. Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism.
Xing S; Li Q; Xiong B; Chen Y; Feng F; Liu W; Sun H
Med Res Rev; 2021 Mar; 41(2):858-901. PubMed ID: 33103262
[TBL] [Abstract][Full Text] [Related]
34. Redox-regulated synthesis of fluorescent polydopamine nanoparticles for detection of butyrylcholinesterase activity.
Li Q; Guo YM; Li GL
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jun; 274():121097. PubMed ID: 35259707
[TBL] [Abstract][Full Text] [Related]
35. Rational construction and evaluation of a dual-functional near-infrared fluorescent probe for the imaging of Amyloid-β and mitochondrial viscosity.
Cao Y; Xu S; Liu J; Zhao S; Yan J
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Feb; 306():123564. PubMed ID: 37871543
[TBL] [Abstract][Full Text] [Related]
36. Influence of lipid imbalance on butyrylcholinesterase activity and biotransformation efficiency.
Sisková K; Bilka F; Adameová A; Balazová A; Mydla M; Pauliková I
Pharmazie; 2012 Apr; 67(4):345-50. PubMed ID: 22570941
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal evaluation of a novel BChE PET tracer as an early
Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J
Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675
[No Abstract] [Full Text] [Related]
38. Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
Darvesh S
Curr Alzheimer Res; 2016; 13(10):1173-7. PubMed ID: 27040140
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
